David E I Pyott is Director of BIOMARIN PHARMACEUTICAL INC. Currently has a direct ownership of 49,750 shares of BMRN, which is worth approximately $3.11 Million. The most recent transaction as insider was on May 21, 2024, when has been sold 4,720 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49.8K
0% 3M change
10.48% 12M change
Total Value Held $3.11 Million

DAVID E I PYOTT Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 21 2024
BUY
Grant, award, or other acquisition
-
4,720 Added 8.67%
49,750 Common Stock
May 23 2023
BUY
Grant, award, or other acquisition
-
4,190 Added 8.51%
45,030 Common Stock
May 24 2022
BUY
Grant, award, or other acquisition
-
4,980 Added 10.87%
40,840 Common Stock
May 25 2021
BUY
Grant, award, or other acquisition
-
5,120 Added 12.49%
35,860 Common Stock

Also insider at

PLRX
PLIANT THERAPEUTICS, INC. Healthcare
ALNY
ALNYLAM PHARMACEUTICALS, INC. Healthcare
DEI

David E I Pyott

Director
Cambridge, MA

Track Institutional and Insider Activities on BMRN

Follow BIOMARIN PHARMACEUTICAL INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMRN shares.

Notify only if

Insider Trading

Get notified when an Biomarin Pharmaceutical Inc insider buys or sells BMRN shares.

Notify only if

News

Receive news related to BIOMARIN PHARMACEUTICAL INC

Track Activities on BMRN